Acute Myeloblastic Leukemia

Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients

Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia

Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCT

Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19

Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia

PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years

Observational Study of Patients Older Than 60 Years With Acute Myeloblastic Leukemia

Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

Natural Killer Index From Hematopoietic Stem Cell Graft

RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML

LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients

Treatment of Acute Myeloblastic Leukemia in Younger Patients

SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia

Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children